Protecting Data in Clinical Trial Disclosure: Best Practices in Personal Data Anonymization
Article
薬事規制関連支援サービス
The reflection here is whether the level of anonymization affects the utility of the data being submitted, so not a re-identification risk, but rather one concerning the viability and usefulness of the data as a result of an anonymization.
DEC 07, 2023
Article
薬事規制関連支援サービス
Understanding Biopharma Regulation
Selected articles on Clinical Trials policy and from Pink Sheet’s analyses of Trends and Regulatory Data. Know when new clinical trial approaches are validated for regulators and how regulators are applying product review policies to specific types of products.
